BD to Announce Financial Results for its Second Quarter of Fiscal 2025

Rhea-AI Summary

BD (NYSE: BDX), a leading global medical technology company, has scheduled a financial results announcement for its second quarter of fiscal year 2025. The company will host an audio webcast on May 1, 2025, at 8 a.m. ET to discuss the quarterly performance ended March 31, 2025.

The presentation will include summary financial information, operational updates, and strategic insights. Investors can access the webcast through BD's investor relations website, where a replay will be available afterward. Prior to the call, BD will release detailed financial information and presentation materials on their investor website.

News Market Reaction – BDX

-6.43%

1 alert

-6.43% News Effect

On the day this news was published, BDX declined 6.43%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

FRANKLIN LAKES, N.J., April 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, May 1, 2025 to discuss the Company's financial results for its second quarter of fiscal year 2025, which ended on March 31, 2025, and to provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors, and a replay will be made available shortly after the call at the same website. Prior to the call, the Company will issue a news release and related presentation materials that will include summary financial information for the quarter.  The news release and related presentation materials will be made available at www.bd.com/investors.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson. 

Contacts:
Media:	Investors:
Troy Kirkpatrick	Adam Reiffe
VP, Public Relations	Sr. Director, Investor Relations
858.617.2361	201.847.6927
troy.kirkpatrick@bd.com	adam.reiffe@bd.com

 

View original content:https://www.prnewswire.com/news-releases/bd-to-announce-financial-results-for-its-second-quarter-of-fiscal-2025-302420164.html

SOURCE BD (Becton, Dickinson and Company)

FAQ

When will BD (BDX) release its Q2 2025 earnings?

BD will release its Q2 fiscal 2025 earnings on Thursday, May 1, 2025, at 8:00 a.m. ET.

How can investors access BD's (BDX) Q2 2025 earnings call?

Investors can access the audio webcast through BD's investor relations website at www.bd.com/investors.

What period does BD's (BDX) Q2 2025 earnings cover?

The earnings report covers the quarter ended March 31, 2025.

Will BD (BDX) provide presentation materials for Q2 2025 earnings?

Yes, BD will release presentation materials and summary financial information prior to the earnings call on www.bd.com/investors.